Supernus Pharmaceuticals (SUPN) Non-Current Deffered Revenue (2011 - 2017)
Supernus Pharmaceuticals (SUPN) recorded Non-Current Deffered Revenue of $1.15 million in Q4 2017, down 23.5% from $1.5 million a year earlier and down 5.9% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Non-Current Deffered Revenue (2011 - 2017) Analysis & Trends
Starting with Q4 2011, Supernus Pharmaceuticals' Non-Current Deffered Revenue history includes 25 quarters.
- Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of 30.0% (FY2012 to FY2017).
- Across earlier years, Non-Current Deffered Revenue came in at $1.5 million in FY2016 (+8.0%), $1.39 million in FY2015 (+9.1%), $1.27 million in FY2014 (-10.1%) and $1.42 million in FY2013 (+358.6%).
- The Q4 2017 figure is the lowest quarterly Non-Current Deffered Revenue since Q2 2013.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for four consecutive quarters, with growth averaging 3.3% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 358.6% in Q4 2013, against a decline of 23.5% in Q4 2017 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.22 million (Q3 2017), $1.29 million (Q2 2017) and $1.37 million (Q1 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.50 Bn | 1.16 Bn | 185.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 1.15 Mn |
| Sep 30, 2017 | 1.22 Mn |
| Jun 30, 2017 | 1.29 Mn |
| Mar 31, 2017 | 1.37 Mn |
| Dec 31, 2016 | 1.50 Mn |
| Sep 30, 2016 | 1.55 Mn |
| Jun 30, 2016 | 1.61 Mn |
| Mar 31, 2016 | 1.66 Mn |
| Dec 31, 2015 | 1.39 Mn |
| Sep 30, 2015 | 1.17 Mn |
| Jun 30, 2015 | 1.20 Mn |
| Mar 31, 2015 | 1.24 Mn |
| Dec 31, 2014 | 1.27 Mn |
| Sep 30, 2014 | 1.31 Mn |
| Jun 30, 2014 | 1.35 Mn |
| Mar 31, 2014 | 1.38 Mn |
| Dec 31, 2013 | 1.42 Mn |
| Sep 30, 2013 | 1.45 Mn |
| Jun 30, 2013 | 738,000.00 |
| Mar 31, 2013 | 774,000.00 |
API Access
Supernus Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();